759 related articles for article (PubMed ID: 28592535)
1. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells
Rangaswamy US; Wang W; Cheng X; McTamney P; Carroll D; Jin H
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592535
[TBL] [Abstract][Full Text] [Related]
2. Roles of the highly conserved amino acids in the globular head and stalk region of the Newcastle disease virus HN protein in the membrane fusion process.
Sun C; Wen H; Chen Y; Chu F; Lin B; Ren G; Song Y; Wang Z
Biosci Trends; 2015 Feb; 9(1):56-64. PubMed ID: 25787910
[TBL] [Abstract][Full Text] [Related]
3. Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses.
Kim SH; Subbiah M; Samuel AS; Collins PL; Samal SK
J Virol; 2011 Sep; 85(17):8582-96. PubMed ID: 21680512
[TBL] [Abstract][Full Text] [Related]
4. Hemagglutinin-Neuraminidase and fusion genes are determinants of NDV thermostability.
Liu T; Song Y; Yang Y; Bu Y; Cheng J; Zhang G; Xue J
Vet Microbiol; 2019 Jan; 228():53-60. PubMed ID: 30593380
[TBL] [Abstract][Full Text] [Related]
5. Measles virus fusion machinery activated by sialic acid binding globular domain.
Talekar A; Moscona A; Porotto M
J Virol; 2013 Dec; 87(24):13619-27. PubMed ID: 24109225
[TBL] [Abstract][Full Text] [Related]
6. Role of the two sialic acid binding sites on the newcastle disease virus HN protein in triggering the interaction with the F protein required for the promotion of fusion.
Mahon PJ; Mirza AM; Iorio RM
J Virol; 2011 Nov; 85(22):12079-82. PubMed ID: 21880745
[TBL] [Abstract][Full Text] [Related]
7. The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion.
Porotto M; Salah Z; DeVito I; Talekar A; Palmer SG; Xu R; Wilson IA; Moscona A
J Virol; 2012 May; 86(10):5730-41. PubMed ID: 22438532
[TBL] [Abstract][Full Text] [Related]
8. Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion.
Connaris H; Takimoto T; Russell R; Crennell S; Moustafa I; Portner A; Taylor G
J Virol; 2002 Feb; 76(4):1816-24. PubMed ID: 11799177
[TBL] [Abstract][Full Text] [Related]
9. Two single mutations in the fusion protein of Newcastle disease virus confer hemagglutinin-neuraminidase independent fusion promotion and attenuate the pathogenicity in chickens.
Ji Y; Liu T; Jia Y; Liu B; Yu Q; Cui X; Guo F; Chang H; Zhu Q
Virology; 2017 Sep; 509():146-151. PubMed ID: 28646649
[TBL] [Abstract][Full Text] [Related]
10. The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effect.
Jung BK; An YH; Jang SH; Jang JJ; Kim S; Jeon JH; Kim J; Song JJ; Jang H
Virol J; 2024 Jan; 21(1):7. PubMed ID: 38178138
[TBL] [Abstract][Full Text] [Related]
11. Attenuate Newcastle disease virus by codon modification of the glycoproteins and phosphoprotein genes.
Wang W; Cheng X; Buske PJ; Suzich JA; Jin H
Virology; 2019 Feb; 528():144-151. PubMed ID: 30616204
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Newcastle disease virus chimeras expressing the Hemagglutinin-Neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone.
Estevez C; King D; Seal B; Yu Q
Virus Res; 2007 Nov; 129(2):182-90. PubMed ID: 17719672
[TBL] [Abstract][Full Text] [Related]
13. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals.
Peeters BP; de Leeuw OS; Verstegen I; Koch G; Gielkens AL
Vaccine; 2001 Feb; 19(13-14):1616-27. PubMed ID: 11166884
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
[TBL] [Abstract][Full Text] [Related]
15. Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy.
He J; Pan Z; Tian G; Liu X; Liu Y; Guo X; An Y; Song L; Wu H; Cao H; Yu D; Che R; Xu P; Rasoul LM; Li D; Yin J
Virus Res; 2016 Aug; 221():23-9. PubMed ID: 27164362
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid substitution in the haemagglutinin-neuraminidase protein of Newcastle disease virus results in increased fusion promotion and decreased neuraminidase activities without changes in virus pathotype.
Estevez C; King DJ; Luo M; Yu Q
J Gen Virol; 2011 Mar; 92(Pt 3):544-51. PubMed ID: 21123551
[TBL] [Abstract][Full Text] [Related]
17. Acidic amino acids increase fusion activity in the specific fusion domain of Newcastle disease virus fusion protein.
Ren G; Zhuang Y; Tian K; Li H; Diao X; Wang M; Zhou N; Wang Z
Can J Microbiol; 2013 Sep; 59(9):641-4. PubMed ID: 24011347
[TBL] [Abstract][Full Text] [Related]
18. Functional chimeric HN glycoproteins derived from Newcastle disease virus and human parainfluenza virus-3.
Deng R; Mirza AM; Mahon PJ; Iorio RM
Arch Virol Suppl; 1997; 13():115-30. PubMed ID: 9413532
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens.
Kumar S; Nayak B; Collins PL; Samal SK
J Virol; 2011 Jul; 85(13):6521-34. PubMed ID: 21525340
[TBL] [Abstract][Full Text] [Related]
20. The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity.
Sergel T; McGinnes LW; Morrison TG
Virology; 1993 Oct; 196(2):831-4. PubMed ID: 8372451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
